Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 25

1.

Islet-Derived eATP Fuels Autoreactive CD8+ T Cells and Facilitates the Onset of Type 1 Diabetes.

Tezza S, Ben Nasr M, D'Addio F, Vergani A, Usuelli V, Falzoni S, Bassi R, Dellepiane S, Fotino C, Rossi C, Maestroni A, Solini A, Corradi D, Giani E, Mameli C, Bertuzzi F, Pezzolesi MG, Wasserfall CH, Atkinson MA, F├╝chtbauer EM, Ricordi C, Folli F, Di Virgilio F, Pileggi A, Dhe-Paganon S, Zuccotti GV, Fiorina P.

Diabetes. 2018 Oct;67(10):2038-2053. doi: 10.2337/db17-1227. Epub 2018 Jul 31.

PMID:
30065030
2.

P2X7R mutation disrupts the NLRP3-mediated Th program and predicts poor cardiac allograft outcomes.

D'Addio F, Vergani A, Potena L, Maestroni A, Usuelli V, Ben Nasr M, Bassi R, Tezza S, Dellepiane S, El Essawy B, Iascone M, Iacovoni A, Borgese L, Liu K, Visner G, Dhe-Paganon S, Corradi D, Abdi R, Starling RC, Folli F, Zuccotti GV, Sayegh MH, Heeger PS, Chandraker A, Grigioni F, Fiorina P.

J Clin Invest. 2018 Aug 1;128(8):3490-3503. doi: 10.1172/JCI94524. Epub 2018 Jul 16.

3.

Prostaglandin E2 Stimulates the Expansion of Regulatory Hematopoietic Stem and Progenitor Cells in Type 1 Diabetes.

Ben Nasr M, D'Addio F, Malvandi AM, Faravelli S, Castillo-Leon E, Usuelli V, Rocchio F, Letizia T, El Essawy AB, Assi E, Mameli C, Giani E, Macedoni M, Maestroni A, Dassano A, Loretelli C, Paroni M, Cannalire G, Biasucci G, Sala M, Biffi A, Zuccotti GV, Fiorina P.

Front Immunol. 2018 Jun 19;9:1387. doi: 10.3389/fimmu.2018.01387. eCollection 2018.

4.

Sodium glucose cotransporters inhibitors in type 1 diabetes.

Dellepiane S, Ben Nasr M, Assi E, Usuelli V, Letizia T, D'Addio F, Zuccotti GV, Fiorina P.

Pharmacol Res. 2018 Jul;133:1-8. doi: 10.1016/j.phrs.2018.04.018. Epub 2018 Apr 22. Review.

PMID:
29689314
5.

PD-L1 genetic overexpression or pharmacological restoration in hematopoietic stem and progenitor cells reverses autoimmune diabetes.

Ben Nasr M, Tezza S, D'Addio F, Mameli C, Usuelli V, Maestroni A, Corradi D, Belletti S, Albarello L, Becchi G, Fadini GP, Schuetz C, Markmann J, Wasserfall C, Zon L, Zuccotti GV, Fiorina P.

Sci Transl Med. 2017 Nov 15;9(416). pii: eaam7543. doi: 10.1126/scitranslmed.aam7543.

6.

Adipose Stem Cell Therapy for Chronic Pancreatitis.

Ben Nasr M, Frumento D, Fiorina P.

Mol Ther. 2017 Nov 1;25(11):2438-2439. doi: 10.1016/j.ymthe.2017.10.007. Epub 2017 Oct 19. No abstract available.

7.

Immunotherapy for type 1 diabetes.

Frumento D, Ben Nasr M, El Essawy B, D'Addio F, Zuccotti GV, Fiorina P.

J Endocrinol Invest. 2017 Aug;40(8):803-814. doi: 10.1007/s40618-017-0641-y. Epub 2017 Mar 4. Review.

PMID:
28260183
8.

Immunoevasion rather than intrinsic oncogenicity may confer MSCs from non-obese diabetic mice the ability to generate neural tumors.

Loretelli C, Moore RF, Ben Nasr M, Dellepiane S, Balan M, Mounayar M, Usuelli V, El Essawy B, D'Addio F, Stemmer-Rachamimov AO, Zuccotti GV, Pal S, Fiorina P, Abdi R.

Acta Diabetol. 2017 Jul;54(7):707-712. doi: 10.1007/s00592-017-0967-0. Epub 2017 Feb 21. No abstract available.

PMID:
28224274
9.

Metabolomic Profiling in Individuals with a Failing Kidney Allograft.

Bassi R, Niewczas MA, Biancone L, Bussolino S, Merugumala S, Tezza S, D'Addio F, Ben Nasr M, Valderrama-Vasquez A, Usuelli V, De Zan V, El Essawy B, Venturini M, Secchi A, De Cobelli F, Lin A, Chandraker A, Fiorina P.

PLoS One. 2017 Jan 4;12(1):e0169077. doi: 10.1371/journal.pone.0169077. eCollection 2017.

10.

CXCR4 antagonism overcomes diabetic stem cell mobilopathy.

Ben Nasr M, Fiorina P.

Atherosclerosis. 2016 Aug;251:512-513. doi: 10.1016/j.atherosclerosis.2016.06.025. Epub 2016 Jun 23. No abstract available.

PMID:
27352994
11.

The use of hematopoietic stem cells in autoimmune diseases.

Ben Nasr M, Bassi R, Usuelli V, Valderrama-Vasquez A, Tezza S, D'Addio F, Fiorina P.

Regen Med. 2016 Jun;11(4):395-405. doi: 10.2217/rme-2015-0057. Epub 2016 May 11. Review.

PMID:
27165670
12.

Circulating IGF-I and IGFBP3 Levels Control Human Colonic Stem Cell Function and Are Disrupted in Diabetic Enteropathy.

D'Addio F, La Rosa S, Maestroni A, Jung P, Orsenigo E, Ben Nasr M, Tezza S, Bassi R, Finzi G, Marando A, Vergani A, Frego R, Albarello L, Andolfo A, Manuguerra R, Viale E, Staudacher C, Corradi D, Batlle E, Breault D, Secchi A, Folli F, Fiorina P.

Cell Stem Cell. 2015 Oct 1;17(4):486-498. doi: 10.1016/j.stem.2015.07.010.

13.

Explaining the increased mortality in type 1 diabetes.

Mameli C, Mazzantini S, Ben Nasr M, Fiorina P, Scaramuzza AE, Zuccotti GV.

World J Diabetes. 2015 Jul 10;6(7):889-95. doi: 10.4239/wjd.v6.i7.889.

14.

Novel therapies for T1D on the horizon.

Ben Nasr M, Fiorina P.

Pharmacol Res. 2015 Aug;98:1-2. doi: 10.1016/j.phrs.2015.03.019. Epub 2015 Apr 13. No abstract available.

PMID:
25882249
15.

Co-transplantation of autologous MSCs delays islet allograft rejection and generates a local immunoprivileged site.

Ben Nasr M, Vergani A, Avruch J, Liu L, Kefaloyianni E, D'Addio F, Tezza S, Corradi D, Bassi R, Valderrama-Vasquez A, Usuelli V, Kim J, Azzi J, El Essawy B, Markmann J, Abdi R, Fiorina P.

Acta Diabetol. 2015 Oct;52(5):917-27. doi: 10.1007/s00592-015-0735-y. Epub 2015 Mar 27.

16.

Interleukin-10+ regulatory B cells arise within antigen-experienced CD40+ B cells to maintain tolerance to islet autoantigens.

Kleffel S, Vergani A, Tezza S, Ben Nasr M, Niewczas MA, Wong S, Bassi R, D'Addio F, Schatton T, Abdi R, Atkinson M, Sayegh MH, Wen L, Wasserfall CH, O'Connor KC, Fiorina P.

Diabetes. 2015 Jan;64(1):158-71. doi: 10.2337/db13-1639. Epub 2014 Sep 3.

17.

The rise, fall, and resurgence of immunotherapy in type 1 diabetes.

Ben Nasr M, D'Addio F, Usuelli V, Tezza S, Abdi R, Fiorina P.

Pharmacol Res. 2015 Aug;98:31-8. doi: 10.1016/j.phrs.2014.07.004. Epub 2014 Aug 6. Review.

PMID:
25107501
18.

Novel immunological strategies for islet transplantation.

Tezza S, Ben Nasr M, Vergani A, Valderrama Vasquez A, Maestroni A, Abdi R, Secchi A, Fiorina P.

Pharmacol Res. 2015 Aug;98:69-75. doi: 10.1016/j.phrs.2014.06.016. Epub 2014 Jul 8. Review.

PMID:
25014184
19.

Autologous nonmyeloablative hematopoietic stem cell transplantation in new-onset type 1 diabetes: a multicenter analysis.

D'Addio F, Valderrama Vasquez A, Ben Nasr M, Franek E, Zhu D, Li L, Ning G, Snarski E, Fiorina P.

Diabetes. 2014 Sep;63(9):3041-6. doi: 10.2337/db14-0295. Epub 2014 Jun 19.

20.

Harnessing the immunological properties of stem cells as a therapeutic option for diabetic nephropathy.

D'Addio F, Trevisani A, Ben Nasr M, Bassi R, El Essawy B, Abdi R, Secchi A, Fiorina P.

Acta Diabetol. 2014 Dec;51(6):897-904. doi: 10.1007/s00592-014-0603-1. Epub 2014 Jun 4. Review.

PMID:
24894496

Supplemental Content

Loading ...
Support Center